載入...
Review of Bone Modifying Agents in Metastatic Breast Cancer
Bone is the most common site for distant metastases in breast cancer and can cause significant morbidity and mortality. Bone modifying agents (BMAs) that include bisphosphonates (BPAs) and denosumab help in decreasing and delaying skeletal-related events (SREs) associated with metastatic breast canc...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7960030/ https://ncbi.nlm.nih.gov/pubmed/33738175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13332 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|